Drug intelligence / Profile preview

Juvéderm VOLIFT + lidocaine

Development stage
Unknown
Lead developer
AbbVie
Modality
Small Molecules
Administration
Intradermal, Submucosal, Subdermal
01

Overview

Juvéderm VOLIFT + lidocaine is a **sterile, cross-linked hyaluronic acid gel** combined with **lidocaine** (a local anaesthetic), intended for **injection into the deep dermis or lips mucosa** for the treatment of **moderate to deep facial wrinkles, folds (e.g., nasolabial and mentolabial folds), contouring, and volume loss** (including lips, forehead, jawline, temple, malar area, and eyebrow)[1][5]. The **hyaluronic acid** functions as a dermal filler to restore volume and smooth skin depressions by physically integrating into the tissue, providing hydration and mechanical support[1][2][3][5]. **Lidocaine** is included to minimize pain and discomfort during the injection procedure[1][5]. Developed using Allergan's **Vycross cross-linking technology** for enhanced smoothness, stability, and relatively long-lasting effects (typically up to 15–18 months)[2][3]. **Primary indications**: treatment of moderate to severe facial wrinkles/facial folds and facial volume restoration[1][2][3][5].

Brand names
Juvéderm VOLIFT + lidocaineJuvéderm VOLIFT with Lidocaine
Other names
Juvéderm VOLIFT + lidocaineJuvéderm VOLIFT with LidocaineJuvéderm VOLIFT
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Juvéderm VOLIFT + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Juvéderm VOLIFT + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call